tiprankstipranks
GeneTether Therapeutics, Inc. (TSE:GTTX)
CNQX:GTTX
Canadian Market

GeneTether Therapeutics, Inc. (GTTX) Financial Statements

2 Followers

GeneTether Therapeutics, Inc. Financial Overview

GeneTether Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is -2.42; GeneTether Therapeutics, Inc. is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -144.22K$ -316.22K$ -27.58K$ -140.22K$ -204.43K
EBITDA$ -144.22K$ -316.22K$ -27.58K$ -140.22K$ -204.43K
Net Income Common Stockholders$ -144.22K$ -316.22K$ -27.58K$ -140.22K$ -204.43K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.25M$ 1.36M$ 1.36M$ 1.43M$ 1.68M
Total Assets$ 1.25M$ 1.41M$ 1.45M$ 1.57M$ 1.69M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.25M$ -1.36M$ -1.36M$ -1.43M$ -1.68M
Total Liabilities$ 54.86K$ 38.59K$ 30.33K$ 38.65K$ 98.10K
Stockholders Equity$ 1.20M$ 1.37M$ 1.42M$ 1.54M$ 1.59M
Cash Flow-
Free Cash Flow$ -78.67K$ -26.24K$ -42.11K$ -298.01K$ -98.50K
Operating Cash Flow$ -78.67K$ -26.24K$ -42.11K$ -298.01K$ -98.50K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

GeneTether Therapeutics, Inc. Earnings and Revenue History

GeneTether Therapeutics, Inc. Debt to Assets

GeneTether Therapeutics, Inc. Cash Flow

GeneTether Therapeutics, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis